Haley Herring, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3304 S M St, Fort Smith, AR 72903 Phone: 479-785-4677 |
Mrs. Katlyn Breann Gaynor, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3205 Jenny Lind Rd, Fort Smith, AR 72901 Phone: 479-785-2501 |
Mrs. Jennylee Rebecca Neal, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2900 Old Greenwood Rd, Ste I, Fort Smith, AR 72903 Phone: 479-648-1888 Fax: 479-648-1999 |
Jessica Paige Mccoy, M.S. CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3205 Jenny Lind Rd, Fort Smith, AR 72901 Phone: 479-785-2501 |
Mrs. Sherry Lynn Swaim, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3009 S 104th St, Fort Smith, AR 72903 Phone: 479-484-1760 Fax: 479-484-1760 |
Ramey Speech Clinic, Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 322 N Greenwood Ave, Fort Smith, AR 72901 Phone: 479-782-9600 Fax: 479-782-1555 |
Mrs. Elizabeth Renee Eoff, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3713 Bayside Cir, Fort Smith, AR 72903 Phone: 479-434-6775 |
Mrs. Debra Richison Stuckey, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1109 Adelaide St, Fort Smith, AR 72901 Phone: 479-573-0500 |
Ms. Cindy Lee Edge, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3205 Jenny Lind Rd, Fort Smith, AR 72901 Phone: 479-785-2501 |
Miss Olivia Morgan Lensing, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10808 Saint Anthony Ct, Fort Smith, AR 72908 Phone: 479-651-6999 |
Mrs. Carrie Ann Childers, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 39 Hiland Street, Fort Smith, AR 72901 Phone: 479-462-4104 |
Mrs. Nancy L Dockery, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7809 S 24th St, Fort Smith, AR 72908 Phone: 479-648-8060 |
Sarah E Fisher Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 S Dallas Street, Fort Smith, AR 72901 Phone: 479-783-3214 |
Jessica Coleman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2900 Old Greenwood Rd, Suite I, Fort Smith, AR 72903 Phone: 479-648-1888 |
Naqing Zheng Li Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6601 Phoenix Ave Ste B, Fort Smith, AR 72903 Phone: 479-785-9091 |
Therapy Connections Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6301 Highway 45, Suite H, Fort Smith, AR 72916 Phone: 479-650-7389 Fax: 479-928-5055 |
Sara Maitland, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3201 Jenny Lind Rd, Fort Smith, AR 72901 Phone: 479-785-2501 |
Sara Payne Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5400 Euper Ln, Fort Smith, AR 72903 Phone: 870-932-3600 |
Mrs. Holly Lanell Craig, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3205 Jenny Lind Rd, Fort Smith, AR 72901 Phone: 479-785-2501 |
Mr. Brian Wakefield, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7201 Blackjack Dr, Fort Smith, AR 72916 Phone: 479-649-7044 |
News Archive
A group of researchers at Immunology Frontier Research Center (IFReC), Osaka University and RIKEN Center for Integrative Medical Sciences jointly clarified the mechanism for inducing germinal-center B cells' differentiation into memory B cells, immune cells that remember antigens, at the molecular level.
Responding to today's release of the Institute of Medicine 's (IOM) new report on the public health dimensions of the epilepsies, a cooperative group of professional and consumer organizations with special interest in epilepsy has issued the following joint statement.
Results from the Phase 2 RESONATE-17 (PCYC-1117) study show IMBRUVICA (ibrutinib) was associated with an 82.6 percent investigator-assessed overall response rate (ORR; the primary endpoint) and a 79 percent progression-free survival (PFS) rate at 12 months in people living with relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have a genetic mutation known as deletion 17p (del 17p).
A larger portion of Africa is currently at high risk for malaria transmission than previously predicted, according to a new University of Florida mapping study.
Benitec Limited, a leading Australian based company specialising in RNA interference (RNAi) technology is pleased to announce the United States Patent and Trademark Office's (USPTO) Board of Patent Appeals and Interferences decision ("the Decision") reversing all previous rejections in the US 6,573,099 (the '099 Graham patent) appeal.
› Verified 8 days ago